Although female, patients over 60 years old and those with a history of other malignant tumors had higher sPD-L1 levels, there was no significant difference in sPD-L1 levels for characteristics in benign and STS patients (Table 1). This evidence concerns the gene SPDL1 and telomere syndrome.